WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel Patrick OdayChairman CEO2025-12-2910,000$124.83
$1.25MSell
Johanna MercierChief Commercial Officer2025-12-153,000$122.00
$366.00kSell
Andrew D. DickinsonChief Financial Officer2025-12-153,000$122.00
$366.00kSell
Daniel Patrick OdayChairman CEO2025-12-104,931$121.34
$598.33kSell
Andrew D. DickinsonChief Financial Officer2025-12-101,745$121.34
$211.74kSell
Johanna MercierChief Commercial Officer2025-12-101,814$121.34
$220.11kSell
Daniel Patrick OdayChairman CEO2025-11-286,788$126.84
$861.02kSell
Jeffrey BluestoneDirector2025-11-285,000$64.92
$324.60kBuy
Jeffrey BluestoneDirector2025-11-285,000$125.08
$625.40kSell
Kelly A. KramerDirector2025-11-282,805$127.10
$356.52kSell

1 of 11

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.59%118,983,644$14.66BInstitution
Blackrock Inc9.37%116,281,391$14.32BInstitution
Fmr LLC4.86%60,316,279$7.43BInstitution
State Street Corp4.76%59,089,305$7.28BInstitution
Capital World Investors3.64%45,179,931$5.57BInstitution
Dodge Cox2.43%30,133,131$3.71BInstitution
Capital Research Global Investors2.42%30,014,046$3.70BInstitution
Geode Capital Management LLC2.41%29,928,986$3.69BInstitution
Price T Rowe Associates Inc2.14%26,503,391$3.26BInstitution
Wellington Management Group LLP2.06%25,618,534$3.16BInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD84.78%1.11%Net SellingNet Selling
PFE63.56%0.27%Net Buying
AMGN78.36%0.99%Net SellingNet Selling
SNY18.86%0.00%
BMY77.56%0.37%Net SellingNet Selling
View Top General Drug Manufacturer Stocks

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 84.78% institutional shareholders, 1.11% Gilead Sciences insiders, and 14.12% retail investors. Vanguard Group Inc is the largest individual Gilead Sciences shareholder, owning 118.98M shares representing 9.59% of the company. Vanguard Group Inc's Gilead Sciences shares are currently valued at $14.60B.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.